Goyal launches five products of startups
The Indian biotechnology industry is on the cusp of entering a new era due to its capacity to provide significant economic growth and development to the people of India and around the world, Piyush Goyal, Minister of Consumer Affairs, Food and Public Distribution told over 6,000 delegates from 50 countries at the Global Bio-India 2021 organized by DBT-BIRAC 1-3 March 2021.
The Minister formally announced the Project Development Cell for Biotechnology and released ‘Indian Bio-economy Report’ by ABLE,&‘Biotech Investment Potential for Indian States Report’ by IFC at a session on Startup Conclave-Innovation Driven Bio-economy on 2 Mar 2021.
Goyal stressed that the combination of BioEconomy with digital and information economy leads to Biotechnology. It is a defining moment for the India’s future economic growth in demonstrating country’s capabilities of becoming the powerhouse of innovation, invention and research.
“We need to ensure that startups should not be afraid of failures. We should extend our support to the start-ups to implement their ideas at the ground level to become commercially viable,” he said.
Goyal also launched products of 5 startups — Blackfrog Technologies Pvt Ltd, Bionic Hope Private Limited, Janitri Innovations Pvt Ltd, Happy Reliable Surgeries Pvt Ltd and VIVIRA Process Technologies Pvt Ltd.
He also launched Tech-Ola designed by Kalam Institute of Health Technology (KIHT). Tech-Ola is a single window e- market place app, which would bring together all public and private sector laboratories, fabrication and prototyping centres to help innovators access services such as testing, machining, prototyping, fabrication, 3-D printing, validation, material characterisation, electrical, electronics and laser services, and batch production.
The consolidated Indian Bio-economy report (Indian Bio Economy Report (IBER) is based on latest data representing the Biotech Sector contribution to the Bio-economy.
This release followed by regular updates unto 2024-25 to track the progress and an overview of Roadmap for the Indian Biotechnology Industry to see if there is a room to accelerate through policy initiatives, what are the gaps and grey areas that can either accentuate or stump Indian Biotech Sector’s US$150 billion Bio-economy journey to 2025.
Dr. Renu Swarup, Secretary, Department of Biotechnology while mentioning that 2020 was the year of challenges but it was also a year of opportunities, remarked how heartening it was to see that despite all the challenges, w
“We have seen the growth in the biotech sector with 850+ startups in the last year (2020) alone, added Dr. Renu Swarup, Secretary, Department of Biotechnology while highlighting 2020 challenges but that led to opportunities.
“Diagnostics have been a key success story for us,” Dr. Swarup pointed out, applauding India’s export PP’s and N95’s due to the stepping up of startups.
The potential of biotech innovation ecosystem and its rapid growth have been well recognized as the key contributors to the growth of global bio-economy, said the Ministry of Science & Technology in a release on the event.
Globally there has been a major thrust towards encouraging the growth of the Start-ups, entrepreneurs, academia, and industry that are further steering the development of the Indian Biotechnology ecosystem, it noted. #pharma #investment #technology #startups #exports #manufacturing #health /fiinews.com
